Akadeum Life Sciences


Akadeum Life Sciences was formed to solve long-standing cell isolation problems with a novel floatation-based target isolation technology. For cell therapy manufacturing, Akadeum is partnering to deploy its proprietary technology that delivers consistent and best-in-class yields of isolated target cells from a gentle process that easily scales. In addition, Akadeum cell activation technology creates workflow advantages and improved expansion and transfection capabilities. The company was the first to commercialize Buoyancy Activated Cell Sorting (BACS™) microbubble kits for research-use-only cell isolation applications. Currently, Akadeum is seeking industry partnerships in cell therapy.